Follow the Nath Bio-Genes (India) Limited share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares are listed on IN IN, under the authority of SEBI (PIT + SAST). Operating in the Chemicals sector, Nath Bio-Genes (India) Limited has published 29 public disclosures. Market capitalisation: €2.8bn. The latest transaction was disclosed on 9 January 2026 (Sale). Among the most active insiders: AGRI-TECH (INDIA) LTD.. Every trade is openly available.
29
Insider Decl.
0
Thresholds
€7m
16 ops.
Buy Volume
€5m
13 ops.
Sell Volume
10Σ signal
Buys €7m€5m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7,357 of 26,179 companies
62.4
score / 100
Value
65
Quality
60
FCF yld-5.0%
Earn yld13%
EV/EBITDA6.8x
ROE6.3%
Gross mgn55%
Net mgn9.4%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.